ODU Digital Commons
metadata only
Dupilumab for Patients with Allergic Fungal Rhinosinusitis
Background Allergic fungal rhinosinusitis (AFRS) is a severe subtype of chronic rhinosinusitis characterized by fungal hypersensitivity and accentuated type 2 inflammation. Dupilumab-a fully human monoclonal antibody blocking interleukin-4/13, approved for type 2 inflammatory diseases, including chr
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Real-World Identification of Eosinophilic COPD Patients Potentially Eligible for Dupilumab: A Retrospective Observational Study.#465368
- 21 CFR Part 344 — Topical Otic Drug Products for Over-the-Counter Human Use#506831
- Role of ABO secretor status in mucosal innate immunity and H. pylori infection#662544
- Micafungin Versus Amphotercine B in Treatment of Invasive Fungal Infection#307474
- mulTiplex Immunoassay qualiTy assuRance Panel#349999
Record · ID 1081219
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive